AIFF
Firefly Neuroscience, Inc.
Price Chart
Latest Quote
$0.86
Current Price| Previous Close | $0.87 |
| Open | $0.89 |
| Day High | $0.90 |
| Day Low | $0.89 |
| Volume | 62,586 |
Stock Information
| Shares Outstanding | 13.49M |
| Cash Equivalents | $4.33M |
| Revenue | $783K |
| Net Income | $-25.60M |
| Sector | Technology |
| Industry | Software - Application |
| Market Cap | $11.55M |
| EPS (TTM) | $-2.26 |
| Exchange | NCM |
đ Custom Metrics & Score
Score: 17/42| Debt to Equity | -1.85 |
| Debt to Earnings | 6.43 |
| Current Ratio | 0.53 |
| Quick Ratio | 0.39 |
| Avg Revenue Growth | 59.38% |
| Profit Margin | -9685.19% |
| Return on Equity | 2789.33% |
| Avg FCF Growth | 18.00% |
| FCF Yield | -56.90% |
Score Explanation: The perfect score is 42/42 based on debt levels, profitability, growth rates, and cash flow metrics. FCF Yield is weighted most heavily as it shows what return the business currently generates.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-02-02 | $0.86 | 62,800 |
| 2026-01-30 | $0.87 | 62,900 |
| 2026-01-29 | $0.92 | 72,500 |
| 2026-01-28 | $0.95 | 102,800 |
| 2026-01-27 | $1.00 | 34,700 |
| 2026-01-26 | $1.01 | 53,300 |
| 2026-01-23 | $1.03 | 49,800 |
| 2026-01-22 | $1.05 | 63,500 |
| 2026-01-21 | $1.02 | 63,800 |
| 2026-01-20 | $0.99 | 56,500 |
| 2026-01-16 | $1.03 | 40,300 |
| 2026-01-15 | $1.04 | 75,400 |
| 2026-01-14 | $1.04 | 93,000 |
| 2026-01-13 | $1.05 | 123,600 |
| 2026-01-12 | $1.11 | 44,500 |
| 2026-01-09 | $1.10 | 83,300 |
| 2026-01-08 | $1.12 | 128,900 |
| 2026-01-07 | $1.07 | 136,100 |
| 2026-01-06 | $1.10 | 190,200 |
| 2026-01-05 | $1.06 | 314,300 |
About Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. was founded in 2006 and is based in Kenmore, New York.
đ° Latest News
No news articles available at the moment. Check back later for updates on AIFF.
Income Statement (Annual)
Revenue
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Revenue | $108,000 | $498,000 | $0 | $32,000 |
| Operating Revenue | $108,000 | $478,000 | $0 | $32,000 |
| Reconciled Cost Of Revenue | - | - | $0 | $0 |
| Cost Of Revenue | - | - | $0 | $0 |
Expenses
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Interest Expense | $69,000 | $18,000 | $574,000 | $135,000 |
| Total Expenses | $9,288,000 | $3,576,000 | $3,252,000 | $4,652,000 |
| Other Income Expense | $-1,209,000 | $494,000 | $37,000 | $374,000 |
| Other Non Operating Income Expenses | $-190,000 | $457,000 | $7,000 | $-3,000 |
| Net Non Operating Interest Income Expense | $-69,000 | $-18,000 | $-574,000 | $-135,000 |
| Interest Expense Non Operating | $69,000 | $18,000 | $574,000 | $135,000 |
| Operating Expense | $9,288,000 | $3,576,000 | $3,252,000 | $4,652,000 |
| Selling And Marketing Expense | $1,201,000 | $639,000 | $65,000 | $20,000 |
| General And Administrative Expense | $6,133,000 | $2,196,000 | $1,915,000 | $1,661,000 |
| Rent Expense Supplemental | - | - | $233,000 | $250,000 |
Income & Earnings
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Income From Continuing Operation Net Minority Interest | $-10,460,000 | $-2,603,000 | $-3,789,000 | $-4,381,000 |
| Net Interest Income | $-69,000 | $-18,000 | $-574,000 | $-135,000 |
| Normalized Income | $-9,654,990 | $-2,632,230 | $-3,819,000 | $-4,758,000 |
| Net Income From Continuing And Discontinued Operation | $-10,460,000 | $-2,603,000 | $-3,789,000 | $-4,381,000 |
| Total Operating Income As Reported | $-10,054,000 | $-3,078,000 | $-3,329,000 | $-4,654,000 |
| Net Income Common Stockholders | $-10,460,000 | $-2,603,000 | $-3,789,000 | $-4,381,000 |
| Net Income | $-10,460,000 | $-2,603,000 | $-3,789,000 | $-4,381,000 |
| Net Income Including Noncontrolling Interests | $-10,460,000 | $-2,603,000 | $-3,789,000 | $-4,381,000 |
| Net Income Continuous Operations | $-10,460,000 | $-2,603,000 | $-3,789,000 | $-4,381,000 |
| Pretax Income | $-10,458,000 | $-2,602,000 | $-3,789,000 | $-4,381,000 |
| Special Income Charges | $-874,000 | $0 | $30,000 | $-174,000 |
| Operating Income | $-9,180,000 | $-3,078,000 | $-3,252,000 | $-4,620,000 |
| Gross Profit | $108,000 | $498,000 | $0 | $32,000 |
| Depreciation Amortization Depletion Income Statement | - | - | $0 | $45,000 |
| Depreciation And Amortization In Income Statement | - | - | $0 | $45,000 |
Per Share Metrics
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Diluted EPS | $-1.60 | $-0.50 | $-0.73 | $-0.84 |
| Basic EPS | $-1.60 | $-0.50 | $-0.73 | $-0.84 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | $-213,990 | $7,770 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-9,303,000 | $-2,621,000 | $-3,231,000 | $-4,194,000 |
| Total Unusual Items | $-1,019,000 | $37,000 | $30,000 | $377,000 |
| Total Unusual Items Excluding Goodwill | $-1,019,000 | $37,000 | $30,000 | $377,000 |
| Reconciled Depreciation | $67,000 | $0 | $14,000 | $429,000 |
| EBITDA (Bullshit earnings) | $-10,322,000 | $-2,584,000 | $-3,201,000 | $-3,817,000 |
| EBIT | $-10,389,000 | $-2,584,000 | $-3,215,000 | $-4,246,000 |
| Diluted Average Shares | $6,546,769 | $5,194,665 | $5,194,665 | $5,194,665 |
| Basic Average Shares | $6,546,769 | $5,194,665 | $5,194,665 | $5,194,665 |
| Diluted NI Availto Com Stockholders | $-10,460,000 | $-2,603,000 | $-3,789,000 | $-4,381,000 |
| Tax Provision | $2,000 | $1,000 | $0 | $0 |
| Impairment Of Capital Assets | $874,000 | $0 | $79,000 | $0 |
| Gain On Sale Of Security | $-145,000 | $37,000 | - | $551,000 |
| Research And Development | $1,954,000 | $741,000 | $1,272,000 | $2,926,000 |
| Selling General And Administration | $7,334,000 | $2,835,000 | $1,980,000 | $1,681,000 |
| Other Gand A | $6,133,000 | $2,196,000 | $920,000 | $417,000 |
| Gain On Sale Of Ppe | - | - | $166,000 | $309,000 |
| Other Special Charges | - | - | $59,000 | $449,000 |
| Write Off | - | - | $-2,000 | $34,000 |
| Rent And Landing Fees | - | - | $233,000 | $250,000 |
| Salaries And Wages | - | - | $762,000 | $994,000 |
Balance Sheet (Annual)
Assets
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Net Tangible Assets | $-555,000 | $-277,000 | $-2,111,000 | $-3,015,000 |
| Total Assets | $4,601,000 | $2,641,000 | $135,000 | $953,000 |
| Total Non Current Assets | $1,973,000 | $386,000 | $52,000 | $250,000 |
| Non Current Prepaid Assets | $1,657,000 | $0 | $52,000 | $61,000 |
| Goodwill And Other Intangible Assets | $180,000 | $386,000 | $0 | $1,000 |
| Other Intangible Assets | $180,000 | $386,000 | - | $1,000 |
| Current Assets | $2,628,000 | $2,255,000 | $83,000 | $703,000 |
| Prepaid Assets | $697,000 | $28,000 | $6,000 | $9,000 |
| Receivables | $121,000 | $84,000 | $19,000 | $41,000 |
| Accounts Receivable | $121,000 | $84,000 | - | - |
| Allowance For Doubtful Accounts Receivable | $-112,000 | $-112,000 | - | - |
| Gross Accounts Receivable | $233,000 | $196,000 | - | - |
| Cash Cash Equivalents And Short Term Investments | $1,810,000 | $2,143,000 | $58,000 | $653,000 |
| Cash And Cash Equivalents | $1,810,000 | $2,143,000 | $58,000 | $653,000 |
| Cash Financial | $1,810,000 | $2,143,000 | - | - |
| Other Receivables | - | - | $19,000 | $41,000 |
Debt
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Debt | $694,000 | - | - | $1,788,000 |
| Current Debt And Capital Lease Obligation | $694,000 | - | - | $1,788,000 |
| Current Debt | $694,000 | - | - | $1,788,000 |
| Other Current Borrowings | $694,000 | - | - | $1,788,000 |
| Net Debt | - | - | - | $1,135,000 |
Liabilities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Total Liabilities Net Minority Interest | $4,976,000 | $2,532,000 | $2,246,000 | $3,967,000 |
| Total Non Current Liabilities Net Minority Interest | $0 | $0 | $0 | $0 |
| Current Liabilities | $4,976,000 | $2,532,000 | $2,246,000 | $3,967,000 |
| Other Current Liabilities | $827,000 | - | - | - |
| Current Deferred Liabilities | $13,000 | $0 | $909,000 | $459,000 |
| Payables And Accrued Expenses | $3,442,000 | $2,532,000 | $1,337,000 | $1,720,000 |
| Payables | $1,816,000 | $630,000 | $597,000 | $967,000 |
| Accounts Payable | $1,816,000 | $630,000 | $420,000 | $500,000 |
Equity
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Common Stock Equity | $-375,000 | $109,000 | $-2,111,000 | $-5,443,000 |
| Total Equity Gross Minority Interest | $-375,000 | $109,000 | $-2,111,000 | $-3,014,000 |
| Stockholders Equity | $-375,000 | $109,000 | $-2,111,000 | $-3,014,000 |
| Retained Earnings | $-87,084,000 | $-76,624,000 | $-73,906,000 | $-67,331,000 |
| Preferred Stock Equity | - | - | - | $2,429,000 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Ordinary Shares Number | $8,122,060 | $8,122,060 | $7,870,251 | $7,870,251 |
| Share Issued | $8,122,060 | $8,122,060 | $7,870,251 | $7,870,251 |
| Tangible Book Value | $-555,000 | $-277,000 | $-2,111,000 | $-5,444,000 |
| Invested Capital | $319,000 | $109,000 | $-2,111,000 | $-3,655,000 |
| Working Capital | $-2,348,000 | $-277,000 | $-2,163,000 | $-3,264,000 |
| Total Capitalization | $-375,000 | $109,000 | $-2,111,000 | $-3,014,000 |
| Additional Paid In Capital | $86,709,000 | $76,733,000 | $71,776,000 | $61,888,000 |
| Capital Stock | $0 | $0 | $19,000 | $2,429,000 |
| Common Stock | $0 | $0 | $19,000 | $0 |
| Preferred Stock | $0 | $0 | $0 | $2,429,000 |
| Current Deferred Revenue | $13,000 | $0 | $909,000 | $459,000 |
| Current Accrued Expenses | $1,626,000 | $1,902,000 | $740,000 | $753,000 |
| Net PPE | $136,000 | $0 | $0 | $188,000 |
| Accumulated Depreciation | $-12,000 | $0 | $-3,219,000 | $-3,789,000 |
| Gross PPE | $148,000 | $0 | $3,219,000 | $3,977,000 |
| Other Properties | $148,000 | - | $2,716,000 | $3,474,000 |
| Dueto Related Parties Current | - | - | $177,000 | $467,000 |
| Machinery Furniture Equipment | - | - | $503,000 | $503,000 |
Cash Flow Statement (Annual)
Free Cash Flow
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-6,570,000 | $-2,558,000 | $-2,892,000 | $-3,820,000 |
Operating Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Operating Cash Flow | $-6,155,000 | $-2,172,000 | $-2,892,000 | $-3,820,000 |
| Cash Flow From Continuing Operating Activities | $-6,155,000 | $-2,172,000 | $-2,892,000 | $-3,820,000 |
| Operating Gains Losses | $156,000 | - | $-28,000 | $-410,000 |
Investing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Capital Expenditure | $-415,000 | $-386,000 | - | - |
| Investing Cash Flow | $-477,000 | $-386,000 | $262,000 | $1,597,000 |
| Cash Flow From Continuing Investing Activities | $-477,000 | $-386,000 | $262,000 | $1,597,000 |
| Net Other Investing Changes | $-62,000 | - | - | - |
Financing Activities
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Issuance Of Capital Stock | $4,308,000 | $4,643,000 | $290,000 | $0 |
| Financing Cash Flow | $6,299,000 | $4,643,000 | $2,035,000 | $2,042,000 |
| Cash Flow From Continuing Financing Activities | $6,299,000 | $4,643,000 | $2,035,000 | $2,042,000 |
| Net Common Stock Issuance | $4,308,000 | $4,643,000 | $290,000 | $0 |
| Common Stock Issuance | $4,308,000 | $4,643,000 | $290,000 | $0 |
Other
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Issuance Of Debt | $1,955,000 | $0 | $1,745,000 | $2,042,000 |
| Interest Paid Supplemental Data | $11,000 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $1,810,000 | $2,143,000 | $58,000 | $653,000 |
| Beginning Cash Position | $2,143,000 | $58,000 | $653,000 | $834,000 |
| Changes In Cash | $-333,000 | $2,085,000 | $-595,000 | $-181,000 |
| Proceeds From Stock Option Exercised | $36,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $1,955,000 | $0 | $1,745,000 | $2,042,000 |
| Net Short Term Debt Issuance | $1,955,000 | $0 | $1,745,000 | $2,042,000 |
| Short Term Debt Issuance | $1,955,000 | $0 | $1,745,000 | $2,042,000 |
| Net Intangibles Purchase And Sale | $-267,000 | $-386,000 | - | - |
| Net PPE Purchase And Sale | $-148,000 | $0 | $262,000 | $597,000 |
| Purchase Of PPE | $-148,000 | $0 | - | - |
| Change In Working Capital | $445,000 | $136,000 | $391,000 | $-193,000 |
| Change In Other Working Capital | $13,000 | $-909,000 | $450,000 | $-370,000 |
| Change In Payables And Accrued Expense | $542,000 | $1,080,000 | $-98,000 | $98,000 |
| Change In Accrued Expense | $-341,000 | $1,047,000 | $-18,000 | $-108,000 |
| Change In Payable | $883,000 | $33,000 | $-80,000 | $206,000 |
| Change In Account Payable | $883,000 | $35,000 | $-80,000 | $206,000 |
| Change In Prepaid Assets | $-73,000 | $30,000 | $12,000 | $53,000 |
| Change In Receivables | $-37,000 | $-65,000 | $27,000 | $26,000 |
| Changes In Account Receivables | $-37,000 | $-65,000 | - | - |
| Other Non Cash Items | $42,000 | - | $460,000 | $127,000 |
| Stock Based Compensation | $2,721,000 | $295,000 | $60,000 | $608,000 |
| Asset Impairment Charge | $874,000 | - | - | - |
| Depreciation Amortization Depletion | $67,000 | $0 | $14,000 | $429,000 |
| Depreciation And Amortization | $67,000 | $0 | $14,000 | $429,000 |
| Depreciation | $67,000 | $0 | $14,000 | $429,000 |
| Gain Loss On Investment Securities | $156,000 | - | - | $-551,000 |
| Net Income From Continuing Operations | $-10,460,000 | $-2,603,000 | $-3,789,000 | $-4,381,000 |
| Net Investment Purchase And Sale | - | - | $0 | $1,000,000 |
| Sale Of Investment | - | - | $0 | $1,000,000 |
| Sale Of PPE | - | - | $262,000 | $597,000 |
| Gain Loss On Sale Of PPE | - | - | $-87,000 | $-308,000 |